BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29880534)

  • 1. Recombinant tissue plasminogen activator treatment of pulmonary embolism also improves deep venous thrombosis.
    Er M
    J Investig Med; 2018 Oct; 66(7):1045-1049. PubMed ID: 29880534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute pancreatitis complicated with deep vein thrombosis and pulmonary embolism: a case report.
    Herath HM; Kulatunga A
    J Med Case Rep; 2016 Jun; 10(1):182. PubMed ID: 27339635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral-popliteal venous segment involvement.
    Lin M; Hsieh JCF; Hanif M; McDaniel A; Chew DK
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):613-620. PubMed ID: 28818211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence and degree of residual venous obstruction on serial duplex imaging is associated with increased risk of recurrence and progression of infrainguinal lower extremity deep venous thrombosis.
    Yoo T; Aggarwal R; Wang TF; Satiani B; Haurani MJ
    J Vasc Surg Venous Lymphat Disord; 2018 Sep; 6(5):575-583.e1. PubMed ID: 29945822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombolytic therapy in patients with pulmonary artery thromboembolism and deep vein thrombosis].
    Zatevakhin II; Zolkin VN; Krivtsov IuV
    Angiol Sosud Khir; 2011; 17(3):85-90. PubMed ID: 22027526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term results after thrombolytic treatment of deep venous thrombosis.
    Schweizer J; Kirch W; Koch R; Elix H; Hellner G; Forkmann L; Graf A
    J Am Coll Cardiol; 2000 Oct; 36(4):1336-43. PubMed ID: 11028492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improving recanalization of deep veins and the "outcomes" of venous thromboembolic complications in prolonged therapy with enoxaparin].
    Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Kirienko AI
    Angiol Sosud Khir; 2010; 17(1):87-94. PubMed ID: 21780625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis.
    Grunwald MR; Hofmann LV
    J Vasc Interv Radiol; 2004 Apr; 15(4):347-52. PubMed ID: 15064337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep vein thrombosis of lower extremity: direct intraclot injection of alteplase once daily with systemic anticoagulation--results of pilot study.
    Chang R; Chen CC; Kam A; Mao E; Shawker TH; Horne MK
    Radiology; 2008 Feb; 246(2):619-29. PubMed ID: 18227550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
    Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
    Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic thrombolysis using tissue plasminogen activator for a patient with paradoxic embolism: a case report.
    Fan Z; Roedersheimer R; Lohr J
    Vasc Endovascular Surg; 2007; 41(2):136-9. PubMed ID: 17463205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of 20 pregnant women with venous thromboembolic disease].
    Sun P; Dong DN
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.
    Röttger C; Madlener K; Heil M; Gerriets T; Walberer M; Wessels T; Bachmann G; Kaps M; Stolz E
    Stroke; 2005 Apr; 36(4):841-6. PubMed ID: 15731475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of retavase and urokinase for management of spontaneous subclavian vein thrombosis.
    Gelabert HA; Jimenez JC; Rigberg DA
    Ann Vasc Surg; 2007 Mar; 21(2):149-54. PubMed ID: 17349354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis in venous thromboembolism. An international perspective.
    Goldhaber SZ
    Chest; 1990 Apr; 97(4 Suppl):176S-181S. PubMed ID: 2108856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter-directed thrombolysis for the management of postpartum deep venous thrombosis.
    Acharya G; Singh K; Hansen JB; Kumar S; Maltau JM
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):155-8. PubMed ID: 15683376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [rt-PA in extracardiac thromboembolic vascular occlusions].
    Cortellaro M; Cofrancesco E; Polli EE
    Ann Ital Med Int; 1990; 5(1):61-9. PubMed ID: 2119673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.